Absci (ABSI) Non-Current Assets (2020 - 2026)

Absci's (ABSI) quarterly Non-Current Assets came in at $63.6 million in Q1 2026, down 16.8% year-on-year from $76.5 million in Q1 2025, and down 4.65% quarter-over-quarter from $66.7 million in Q4 2025.

Absci (ABSI) Non-Current Assets (2020 - 2026) Analysis & Trends

Absci has disclosed Non-Current Assets across 7 years of filings, most recently posting $63.6 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $63.6 million, down 16.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $272.8 million (down 17.74% YoY), and the FY2025 annual result was $66.7 million, down 16.36% from the prior year.
  • Non-Current Assets came in at $63.6 million for Q1 2026 at Absci, down from $66.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $139.5 million in Q1 2022 to a low of $63.6 million in Q1 2026.
  • The 5-year median for Non-Current Assets is $93.1 million (2024), against an average of $99.0 million.
  • Across the five-year window, Non-Current Assets declined 4.32% in 2022 and decreased 28.65% in 2024, its largest moves.
  • Absci's Non-Current Assets stood at $134.1 million in 2022, then slipped by 27.9% to $96.7 million in 2023, then declined by 17.52% to $79.8 million in 2024, then dropped by 16.36% to $66.7 million in 2025, then retreated by 4.65% to $63.6 million in 2026.
  • The last three Non-Current Assets figures came in at $63.6 million (Q1 2026), $66.7 million (Q4 2025), and $70.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Absci 1.13 Bn 1.01 Bn - 63.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 63.62 Mn
Dec 31, 2025 66.72 Mn
Sep 30, 2025 70.00 Mn
Jun 30, 2025 72.49 Mn
Mar 31, 2025 76.47 Mn
Dec 31, 2024 79.78 Mn
Sep 30, 2024 85.09 Mn
Jun 30, 2024 90.34 Mn
Mar 31, 2024 93.10 Mn
Dec 31, 2023 96.72 Mn
Sep 30, 2023 101.63 Mn
Jun 30, 2023 106.12 Mn
Mar 31, 2023 130.49 Mn
Dec 31, 2022 134.15 Mn
Sep 30, 2022 138.01 Mn
Jun 30, 2022 138.43 Mn
Mar 31, 2022 139.50 Mn
Dec 31, 2021 153.12 Mn
Sep 30, 2021 148.45 Mn
Jun 30, 2021 144.68 Mn